{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "21605007", "DateCompleted": {"Year": "2011", "Month": "09", "Day": "15"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.3109/08958378.2011.572096"], "ArticleDate": [], "Journal": {"ISSN": "1091-7691", "JournalIssue": {"Volume": "23", "Issue": "6", "PubDate": {"Year": "2011", "Month": "May"}}, "Title": "Inhalation toxicology", "ISOAbbreviation": "Inhal Toxicol"}, "ArticleTitle": "Airway purinergic responses in healthy, atopic nonasthmatic, and atopic asthmatic subjects exposed to ozone.", "Pagination": {"StartPage": "324", "EndPage": "330", "MedlinePgn": "324-30"}, "Abstract": {"AbstractText": ["Ozone exposure triggers airway inflammatory responses that may be influenced by biologically active purine metabolites.", "To examine the relationships between airway purine metabolites and established inflammatory markers of ozone exposure, and to determine if these relationships are altered in individuals with atopy or asthma.", "Mass spectrometry was utilized to measure concentrations of purine metabolites (adenosine monophosphate [AMP], adenosine, hypoxanthine, uric acid) and non-purine metabolites (taurine, urea, phenylalanine, tyrosine) in induced sputum obtained from 31 subjects with normal lung function (13 healthy controls, eight atopic nonasthmatics, and 10 atopic asthmatic [AA]) before and 4 h after ozone exposure.", "At baseline, the purines AMP and hypoxanthine correlated with multiple inflammatory markers including neutrophil counts and the cytokines interleukin (IL)-6, IL-8, tumor necrosis factor alpha (TNF-\u03b1), and IL-1\u03b2 (r ranged from 0.41 to 0.66, all P < 0.05). Following ozone exposure, these purines remained correlated with IL-6, IL-8, and TNF-\u03b1 (r = 0.37-0.68). However, AMP and hypoxanthine increased significantly post ozone exposure in atopic nonasthmatics but not in AA. In contrast, the non-purine metabolite taurine correlated with baseline neutrophil counts (r = 0.56) and IL-6 (r = 0.53) and was elevated post-exposure in both atopic cohorts.", "The purine metabolites AMP and hypoxanthine are correlated with multiple inflammatory markers at baseline and after ozone exposure. However, changes in these purine metabolites after ozone appear to differ from other inflammatory markers, with less response in AA relative to atopic nonasthmatics. Purine metabolites may play a role in the signaling responses to ozone, but these responses may be altered in subjects with asthma."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Pulmonology, University of North Carolina at Chapel Hill, 27517, USA. Charles_Esther@med.unc.edu"}], "Identifier": [], "LastName": "Esther", "ForeName": "Charles R", "Initials": "CR", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Peden", "ForeName": "David B", "Initials": "DB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Alexis", "ForeName": "Neil E", "Initials": "NE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hernandez", "ForeName": "Michelle L", "Initials": "ML"}], "GrantList": [{"GrantID": "RC1 ES018417", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "UL1 RR025747-05", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "P01AT002620", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P01 AT002620", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "KL2 RR025746-05", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "KL2 RR025746", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "KL2RR025746", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES010126", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL089708", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "M01 RR000046", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "KL2 TR001109", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}, {"GrantID": "R01ES012706", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "1K23HL089708", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "M01RR00046", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES-10126", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "M01 RR000046-39", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "U19 AI077437", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES012706", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "UL1RR025747", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "UL1 RR025747", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "U19AI077437", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "P30ES010126", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Inhal Toxicol", "NlmUniqueID": "8910739", "ISSNLinking": "0895-8378"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Purines"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["metabolism"], "DescriptorName": "Asthma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hypersensitivity"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Inhalation Exposure"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["analysis", "metabolism"], "DescriptorName": "Purines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sputum"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "AHMAD S, AHMAD A, MCCONVILLE G, SCHNEIDER BK, ALLEN CB, MANZER R, MASON RJ, WHITE CW. Lung epithelial cells release ATP during ozone exposure: signaling for cell survival. Free Radic Biol Med. 2005;39:213\u201326.", "ArticleIdList": ["15964513"]}, {"Citation": "BOURS MJ, SWENNEN EL, DI VIRGILIO F, CRONSTEIN BN, DAGNELIE PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006;112:358\u2013404.", "ArticleIdList": ["16784779"]}, {"Citation": "BURNSTOCK G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev. 2006a;58:58\u201386.", "ArticleIdList": ["16507883"]}, {"Citation": "BURNSTOCK G. Purinergic signalling. Br J Pharmacol. 2006b;147(Suppl 1):S172\u201381.", "ArticleIdList": ["PMC1760723", "16402102"]}, {"Citation": "CHEN Y, CORRIDEN R, INOUE Y, YIP L, HASHIGUCHI N, ZINKERNAGEL A, NIZET V, INSEL PA, JUNGER WG. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science. 2006;314:1792\u20135.", "ArticleIdList": ["17170310"]}, {"Citation": "CIENCEWICKI J, TRIVEDI S, KLEEBERGER SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol. 2008;122:456\u2013468.", "ArticleIdList": ["PMC2693323", "18774381"]}, {"Citation": "CSOMA Z, HUSZAR E, VIZI E, VASS G, SZABO Z, HERJAVECZ I, KOLLAI M, HORVATH I. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J. 2005;25:873\u20138.", "ArticleIdList": ["15863645"]}, {"Citation": "DEPUYDT PO, LAMBRECHT BN, JOOS GF, PAUWELS RA. Effect of ozone exposure on allergic sensitization and airway inflammation induced by dendritic cells. Clinical & Experimental Allergy. 2002;32:391\u2013396.", "ArticleIdList": ["11940069"]}, {"Citation": "DEVLIN RB, MCDONNELL WF, MANN R, BECKER S, HOUSE DE, SCHREINEMACHERS D, KOREN HS. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol. 1991;4:72\u201381.", "ArticleIdList": ["1846079"]}, {"Citation": "DRIVER AG, KUKOLY CA, ALI S, MUSTAFA SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993;148:91\u20137.", "ArticleIdList": ["8317821"]}, {"Citation": "ELTZSCHIG HK, WEISSMULLER T, MAGER A, ECKLE T. Nucleotide metabolism and cell-cell interactions. Methods Mol Biol. 2006;341:73\u201387.", "ArticleIdList": ["16799190"]}, {"Citation": "ESTHER CR, JR, ALEXIS NE, CLAS ML, LAZAROWSKI ER, DONALDSON SH, RIBEIRO CM, MOORE CG, DAVIS SD, BOUCHER RC. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J. 2008a;31:949\u201356.", "ArticleIdList": ["PMC2723793", "18256064"]}, {"Citation": "ESTHER CR, JR, BOYSEN G, OLSEN BM, COLLINS LB, GHIO AJ, SWENBERG JW, BOUCHER RC. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2009;296:L987\u2013993.", "ArticleIdList": ["PMC2692804", "19304910"]}, {"Citation": "ESTHER CR, JR, JASIN HM, COLLINS LB, SWENBERG JA, BOYSEN G. A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate. Rapid Commun Mass Spectrom. 2008b;22:701\u20135.", "ArticleIdList": ["PMC2578813", "18257110"]}, {"Citation": "FUKUDA K, HIRAI Y, YOSHIDA H, NAKAJIMA T, USUI T. Free amino acid content of lymphocytes and granulocytes compared. Clin Chem. 1982;28:1758\u20131761.", "ArticleIdList": ["7094296"]}, {"Citation": "GASSE P, RITEAU N, CHARRON S, GIRRE S, FICK L, PETRILLI V, TSCHOPP J, LAGENTE V, QUESNIAUX VFJ, RYFFEL B, COUILLIN I. Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis. Am J Respir Crit Care Med. 2009;179:903\u2013913.", "ArticleIdList": ["19218193"]}, {"Citation": "HASKO G, SZABO C, NEMETH ZH, KVETAN V, PASTORES SM, VIZI ES. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol. 1996;157:4634\u201340.", "ArticleIdList": ["8906843"]}, {"Citation": "HEE SUN P, SO RI KIM, YONG CHUL LEE. Impact of oxidative stress on lung diseases. Respirology. 2009;14:27\u201338.", "ArticleIdList": ["19144046"]}, {"Citation": "HERNANDEZ ML, LAY JC, HARRIS B, ESTHER CR, JR, BRICKEY WJ, BROMBERG PA, DIAZ-SANCHEZ D, DEVLIN RB, KLEEBERGER SR, ALEXIS NE, PEDEN DB. Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone. J Allergy Clin Immunol. 2010;126:537\u2013544.e1.", "ArticleIdList": ["PMC2949284", "20816188"]}, {"Citation": "HOLLINGSWORTH JW, KLEEBERGER SR, FOSTER WM. Ozone and pulmonary innate immunity. Proc Am Thorac Soc. 2007;4:240\u20136.", "ArticleIdList": ["PMC2647625", "17607006"]}, {"Citation": "HUSZAR E, VASS G, VIZI E, CSOMA Z, BARAT E, MOLNAR VILAGOS G, HERJAVECZ I, HORVATH I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J. 2002;20:1393\u20138.", "ArticleIdList": ["12503694"]}, {"Citation": "JASPERS I, FLESCHER E, CHEN LC. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am J Physiol Lung Cell Mol Physiol. 1997;272:L504\u2013511.", "ArticleIdList": ["9124608"]}, {"Citation": "KNUDSON RJ, SLATIN RC, LEBOWITZ MD, BURROWS B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis. 1976;113:587\u2013600.", "ArticleIdList": ["1267262"]}, {"Citation": "LAY JC, ALEXIS NE, KLEEBERGER SR, ROUBEY RA, HARRIS BD, BROMBERG PA, HAZUCHA MJ, DEVLIN RB, PEDEN DB. Ozone enhances markers of innate immunity and antigen presentation on airway monocytes in healthy individuals. J Allergy Clin Immunol. 2007;120:719\u201322.", "ArticleIdList": ["17586033"]}, {"Citation": "LEARN DB, FRIED VA, THOMAS EL. Taurine and hypotaurine content of human leukocytes. J Leukoc Biol. 1990;48:174\u2013182.", "ArticleIdList": ["2370482"]}, {"Citation": "LENNON PF, TAYLOR CT, STAHL GL, COLGAN SP. Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med. 1998;188:1433\u201343.", "ArticleIdList": ["PMC2213403", "9782120"]}, {"Citation": "LOUGHLIN CE, ESTHER CR, JR, LAZAROWSKI ER, ALEXIS NE, PEDEN DB. Neutrophilic inflammation is associated with altered airway hydration in stable asthmatics. Respir Med 2009", "ArticleIdList": ["PMC2818060", "19646854"]}, {"Citation": "MOHSENIN A, BLACKBURN MR. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2006;12:54\u20139.", "ArticleIdList": ["16357580"]}, {"Citation": "QUINLAN GJ, LAMB NJ, TILLEY R, EVANS TW, GUTTERIDGE JM. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med. 1997;155:479\u201384.", "ArticleIdList": ["9032182"]}, {"Citation": "SELTZER J, BIGBY BG, STULBARG M, HOLTZMAN MJ, NADEL JA, UEKI IF, LEIKAUF GD, GOETZL EJ, BOUSHEY HA. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol. 1986;60:1321\u20131326.", "ArticleIdList": ["3084448"]}, {"Citation": "SITARAMAN SV, MERLIN D, WANG L, WONG M, GEWIRTZ AT, SI-TAHAR M, MADARA JL. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest. 2001;107:861\u20139.", "ArticleIdList": ["PMC199578", "11285305"]}, {"Citation": "SUN Y, WU F, SUN F, HUANG P. Adenosine Promotes IL-6 Release in Airway Epithelia. J Immunol. 2008;180:4173\u20134181.", "ArticleIdList": ["18322229"]}, {"Citation": "VASS G, HORVATH I. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr Med Chem. 2008;15:917\u201322.", "ArticleIdList": ["18473799"]}, {"Citation": "VIZI E, HUSZAR E, CSOMA Z, BOSZORMENYI-NAGY G, BARAT E, HORVATH I, HERJAVECZ I, KOLLAI M. Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol. 2002;109:446\u20138.", "ArticleIdList": ["11897989"]}, {"Citation": "WITKO-SARSAT V, DELACOURT C, RABIER D, BARDET J, NGUYEN AT, DESCAMPS-LATSCHA B. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med. 1995;152:1910\u20131916.", "ArticleIdList": ["8520754"]}]}], "History": [{"Year": "2011", "Month": "5", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "5", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "9", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21605007", "NIHMS317895", "PMC3175355", "10.3109/08958378.2011.572096"]}}], "PubmedBookArticle": []}